Real-time enrollment status for this prostate cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 4:57 PM UTC
| NCT Number | NCT05832086 |
| Recruiting Status | Recruiting |
| Condition | Prostate Cancer |
| Phase | PHASE2 |
| Target Enrollment | 138 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Stephen Freedland |
| Last Updated on CT.gov | August 10, 2026 (Aug 10, 2026) |
As of October 16, 2026: Clinical trial NCT05832086 is currently recruiting participants. This phase2 study for prostate cancer is actively seeking new participants at 3 locations across the United States. The study is sponsored by Stephen Freedland. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05832086 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05832086 was last updated Aug 10, 2026 (August 10, 2026). HelloStudys verifies this status automatically.